Zhejiang Wecome Pharmaceutical Company Limited’s Net Profit Rose 13.9% in First Half of 2023

Zhejiang Wecome Pharmaceutical Company Limited (浙江维康药业股份有限公司) (300878.SZ) reported a net profit of 65.5 million yuan in the first half of 2023, up 13.9% year-on-year.

Meanwhile, the company posted 316.4 million yuan in revenue, up 7% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 550 million yuan in total liabilities, with a liability-to-asset ratio of 27.1%.